CNS vs VCTR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 29, 2026

CNS

70.0
AI Score
VS
CNS Wins

VCTR

68.8
AI Score

Investment Advisor Scores

CNS

Sep 29, 2026
70score
Recommendation
HOLD

VCTR

Sep 29, 2026
69score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CNS VCTR Winner
Forward P/E 18.4502 12.6904 VCTR
PEG Ratio 1.6881 0 Tie
Revenue Growth 12.2% 24.0% VCTR
Earnings Growth 31.9% 148.0% VCTR
Tradestie Score 70.0/100 68.8/100 CNS
Profit Margin 28.8% 29.6% VCTR
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CNS 1M: -5.6% · 3M: -6.9% VCTR 1M: -1.2% · 3M: +27.4%

Current Technical Phase

CNS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.8%), weak momentum, RSI 36

RSI (14): 36.2 · Price: $73.12

VCTR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.0% over 20 days), RSI 57

RSI (14): 56.6 · Price: $111.74

Fundamentals Snapshot

Metric CNS VCTR
Market Cap — —
Forward P/E 18.4 13.1
Trailing P/E 22.4 20.1
Revenue (TTM) — —
Revenue Growth 0.1% 0.2%
Gross Margin 0.5% 0.6%
Operating Margin 0.3% 0.5%
EPS 3.26 5.49
Dividend Yield 0.04% 0.02%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.